Truman Brown, PhD

Concepts (283)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Magnetic Resonance Spectroscopy
12
2011
338
2.210
Why?
Magnetic Resonance Imaging
25
2015
2134
1.890
Why?
Brain
16
2015
2106
1.540
Why?
Cerebrovascular Circulation
8
2011
282
1.010
Why?
Image Enhancement
5
2010
140
0.910
Why?
Hippocampus
7
2012
426
0.910
Why?
Cerebrovascular Disorders
3
2010
181
0.830
Why?
Artifacts
3
2009
124
0.810
Why?
Blood Flow Velocity
2
2011
172
0.800
Why?
Arteries
2
2011
107
0.780
Why?
Cognition Disorders
3
2009
321
0.700
Why?
beta-Thalassemia
2
2010
17
0.700
Why?
Algorithms
9
2011
1159
0.670
Why?
Weightlessness Simulation
1
2015
6
0.600
Why?
Head-Down Tilt
1
2015
7
0.600
Why?
Space Flight
1
2015
38
0.550
Why?
Echo-Planar Imaging
2
2011
17
0.530
Why?
Cerebral Infarction
2
2012
100
0.530
Why?
Hemosiderin
3
2011
9
0.520
Why?
Memory Disorders
2
2012
110
0.510
Why?
Ferritins
3
2011
48
0.510
Why?
Image Interpretation, Computer-Assisted
4
2010
232
0.510
Why?
Liver
3
2010
1081
0.500
Why?
Biomarkers, Tumor
3
2006
493
0.470
Why?
Electroencephalography
3
2009
401
0.470
Why?
Geriatric Assessment
2
2009
106
0.440
Why?
Auditory Perception
2
2009
92
0.440
Why?
Metabolomics
1
2011
26
0.430
Why?
Image Processing, Computer-Assisted
8
2011
664
0.420
Why?
Biomarkers
3
2011
1541
0.420
Why?
Sensitivity and Specificity
14
2010
4741
0.420
Why?
Malaria, Cerebral
1
2009
3
0.400
Why?
Cognitive Reserve
1
2009
6
0.400
Why?
Dementia, Vascular
1
2009
16
0.400
Why?
Optical Devices
1
2009
7
0.400
Why?
Head Movements
1
2009
12
0.400
Why?
Phosphorus Compounds
2
2006
2
0.390
Why?
Event-Related Potentials, P300
1
2009
2
0.390
Why?
Mass Spectrometry
2
2011
288
0.390
Why?
Ballistocardiography
1
2009
2
0.390
Why?
Iron Overload
2
2009
26
0.380
Why?
Signal Processing, Computer-Assisted
3
2009
99
0.380
Why?
Orientation
1
2009
45
0.380
Why?
Diffusion Magnetic Resonance Imaging
2
2009
226
0.380
Why?
Reproducibility of Results
11
2010
2019
0.370
Why?
Homeostasis
1
2010
268
0.360
Why?
Male
30
2015
36233
0.360
Why?
Aging
4
2009
889
0.360
Why?
Parkinsonian Disorders
1
2008
42
0.360
Why?
Humans
43
2015
68792
0.360
Why?
Aged, 80 and over
11
2012
4729
0.360
Why?
Phosphorylcholine
3
2004
12
0.350
Why?
Ethanolamines
3
2004
31
0.350
Why?
Female
32
2015
39962
0.340
Why?
Residence Characteristics
2
2009
242
0.340
Why?
Tibia
1
2008
91
0.330
Why?
Phosphorus
2
2006
64
0.330
Why?
Peptide Mapping
1
2006
39
0.320
Why?
Imaging, Three-Dimensional
1
2008
310
0.320
Why?
Computer Graphics
1
2006
33
0.320
Why?
Databases, Protein
1
2006
48
0.310
Why?
Myocardium
3
2011
1173
0.310
Why?
Brain Mapping
8
2009
500
0.310
Why?
Cohort Studies
8
2010
2250
0.310
Why?
Proteome
1
2006
80
0.300
Why?
Diagnosis, Computer-Assisted
1
2006
75
0.300
Why?
Lactates
1
2004
28
0.280
Why?
Metabolism, Inborn Errors
1
2004
18
0.280
Why?
Lymphocytes
2
2003
225
0.280
Why?
Brain Ischemia
2
2010
630
0.280
Why?
User-Computer Interface
1
2006
227
0.280
Why?
Urine
1
2004
51
0.280
Why?
Aged
17
2012
14503
0.280
Why?
Pattern Recognition, Automated
1
2004
70
0.270
Why?
Principal Component Analysis
3
2011
50
0.270
Why?
Lymphoma, Non-Hodgkin
1
2004
34
0.270
Why?
Iron
2
2011
195
0.270
Why?
Software
1
2006
403
0.260
Why?
Stroke
4
2012
2045
0.260
Why?
Spin Labels
4
2011
27
0.250
Why?
Drug-Related Side Effects and Adverse Reactions
1
2004
128
0.250
Why?
Organophosphates
1
2002
7
0.250
Why?
Neuropsychological Tests
6
2009
483
0.240
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2002
40
0.240
Why?
Thalassemia
2
2011
7
0.210
Why?
Hypertension
1
2010
1462
0.210
Why?
Nerve Fibers, Myelinated
2
2010
48
0.200
Why?
New York City
2
2010
49
0.200
Why?
Neoplasms
3
2006
1586
0.200
Why?
Gene Expression Profiling
3
2008
483
0.190
Why?
Atrophy
2
2009
105
0.190
Why?
African Americans
2
2009
1898
0.180
Why?
Alzheimer Disease
3
2008
528
0.180
Why?
Prospective Studies
3
2012
3543
0.170
Why?
Drug Delivery Systems
3
2008
230
0.170
Why?
Blood-Brain Barrier
2
2008
89
0.170
Why?
Adult
13
2011
20717
0.160
Why?
Bed Rest
1
2015
17
0.150
Why?
Hydrazines
2
2004
23
0.140
Why?
Animals
10
2011
20109
0.130
Why?
Rats, Wistar
2
2004
357
0.130
Why?
Phantoms, Imaging
2
2011
177
0.130
Why?
Predictive Value of Tests
2
2009
1433
0.120
Why?
Phosphorus Isotopes
4
2009
9
0.120
Why?
Tissue Distribution
2
2010
279
0.120
Why?
Equipment Failure Analysis
2
2009
121
0.120
Why?
Follow-Up Studies
2
2009
3159
0.110
Why?
Neurologic Examination
2
2009
106
0.110
Why?
Models, Statistical
3
2011
436
0.110
Why?
Magnetics
2
2009
55
0.110
Why?
Models, Biological
2
2007
958
0.110
Why?
Acoustic Stimulation
2
2009
203
0.110
Why?
Risk Factors
4
2010
5494
0.110
Why?
Perfusion
1
2011
126
0.110
Why?
Cerebral Arteries
2
2009
49
0.110
Why?
Motion
1
2011
25
0.110
Why?
X-Rays
1
2011
51
0.110
Why?
Equipment Design
2
2009
493
0.110
Why?
Dentate Gyrus
2
2007
11
0.110
Why?
Diagnostic Imaging
1
2011
194
0.100
Why?
Chelation Therapy
2
2011
18
0.100
Why?
Young Adult
3
2010
5496
0.100
Why?
Sound
1
2009
17
0.100
Why?
Time Factors
4
2011
4527
0.100
Why?
Habituation, Psychophysiologic
1
2009
22
0.100
Why?
Transducers
1
2009
21
0.090
Why?
Middle Aged
9
2009
20597
0.090
Why?
Elasticity Imaging Techniques
1
2008
14
0.090
Why?
Decision Support Techniques
2
1999
3221
0.090
Why?
Caribbean Region
1
2008
9
0.090
Why?
Biopsy
2
1999
3573
0.090
Why?
Anatomy, Cross-Sectional
1
2008
5
0.090
Why?
United States
2
2015
7025
0.090
Why?
Self Concept
1
2009
117
0.090
Why?
Ultrasonic Therapy
1
2008
19
0.090
Why?
Comorbidity
2
2010
1386
0.090
Why?
Kidney Medulla
1
2008
14
0.090
Why?
Electrodes
1
2009
147
0.090
Why?
Computer-Aided Design
1
2009
92
0.090
Why?
Prevalence
2
2010
1569
0.090
Why?
Leukoaraiosis
1
2008
13
0.090
Why?
Disability Evaluation
1
2010
292
0.090
Why?
Rats
3
2008
5070
0.090
Why?
Adolescent
3
2010
8641
0.090
Why?
Prognosis
2
2004
2044
0.090
Why?
Vascular Diseases
1
2008
97
0.090
Why?
Sonication
1
2007
8
0.090
Why?
Ferric Compounds
1
2008
45
0.090
Why?
Neurotoxicity Syndromes
1
2007
17
0.090
Why?
Histocompatibility Antigens Class II
1
2008
77
0.090
Why?
Clinical Competence
2
1999
3653
0.090
Why?
Protons
2
2009
60
0.080
Why?
Stress, Mechanical
1
2008
207
0.080
Why?
Olfactory Bulb
1
2006
14
0.080
Why?
Severity of Illness Index
2
2010
1779
0.080
Why?
Phospholipids
2
2008
108
0.080
Why?
Mice
5
2011
8108
0.080
Why?
Oxygen
1
2009
379
0.080
Why?
Gadolinium
1
2007
85
0.080
Why?
Data Interpretation, Statistical
1
2008
320
0.080
Why?
Olfaction Disorders
1
2008
95
0.080
Why?
Cattle
1
2008
490
0.080
Why?
Database Management Systems
1
2006
25
0.080
Why?
Dementia
1
2008
150
0.080
Why?
Regression Analysis
1
2008
718
0.080
Why?
Magnetic Resonance Angiography
1
2007
176
0.080
Why?
Amyloid beta-Peptides
1
2007
174
0.080
Why?
Psychomotor Performance
1
2008
207
0.080
Why?
Information Storage and Retrieval
1
2006
48
0.080
Why?
Diagnosis, Differential
1
2009
1124
0.080
Why?
Cross-Sectional Studies
2
2009
2142
0.070
Why?
Smell
1
2006
125
0.070
Why?
Homocysteine
1
2005
26
0.070
Why?
Hemoglobin E
1
2005
2
0.070
Why?
Breast Neoplasms
2
1999
4510
0.070
Why?
Transfusion Reaction
1
2005
35
0.070
Why?
Iron Chelating Agents
1
2005
24
0.070
Why?
Deferoxamine
1
2005
39
0.070
Why?
Combined Modality Therapy
2
2005
952
0.070
Why?
Fetal Death
1
2004
57
0.070
Why?
Nanoparticles
1
2008
234
0.070
Why?
Spectrum Analysis
1
2004
87
0.070
Why?
Carcinogens
1
2004
86
0.070
Why?
Databases as Topic
1
2004
48
0.070
Why?
Fetal Growth Retardation
1
2004
51
0.070
Why?
Prenatal Diagnosis
1
2004
69
0.070
Why?
Multicenter Studies as Topic
1
2004
191
0.070
Why?
Cognition
1
2008
479
0.070
Why?
Blood Pressure
1
2010
1366
0.070
Why?
Models, Genetic
1
2004
162
0.060
Why?
Gestational Age
1
2004
375
0.060
Why?
Structure-Activity Relationship
1
2004
403
0.060
Why?
Phosphocreatine
1
2003
20
0.060
Why?
Neuromuscular Diseases
1
2003
13
0.060
Why?
Biophysical Phenomena
1
2003
26
0.060
Why?
Biophysics
1
2003
39
0.060
Why?
Glycerylphosphorylcholine
1
2002
1
0.060
Why?
ROC Curve
1
2004
371
0.060
Why?
Phosphatidylethanolamines
1
2002
20
0.060
Why?
Myocardial Infarction
1
2008
790
0.060
Why?
Nucleotides
1
2002
25
0.060
Why?
Chi-Square Distribution
1
2004
527
0.060
Why?
Nucleosides
1
2002
10
0.060
Why?
Oligonucleotide Array Sequence Analysis
1
2004
317
0.060
Why?
Esters
1
2002
18
0.060
Why?
Nuclear Magnetic Resonance, Biomolecular
1
2002
86
0.060
Why?
Bayes Theorem
1
2004
276
0.060
Why?
Lymphoma
1
2003
111
0.060
Why?
Risk Assessment
2
2008
1934
0.060
Why?
Schizophrenia
1
2003
208
0.050
Why?
Neurons
1
2007
846
0.050
Why?
Exercise
1
2007
611
0.050
Why?
Muscle, Skeletal
1
2004
376
0.050
Why?
Dose-Response Relationship, Drug
1
2004
1720
0.050
Why?
Pregnancy
1
2004
2231
0.050
Why?
Case-Control Studies
1
2002
1488
0.040
Why?
Tomography, X-Ray Computed
1
2008
2242
0.040
Why?
Reference Values
2
2009
570
0.040
Why?
New York
2
2008
217
0.040
Why?
Carcinoma, Squamous Cell
1
2002
608
0.040
Why?
Linear Models
2
2009
511
0.040
Why?
Retrospective Studies
1
2009
6845
0.040
Why?
Head and Neck Neoplasms
1
2002
533
0.040
Why?
Multivariate Analysis
2
2009
1038
0.040
Why?
Costs and Cost Analysis
2
1999
3217
0.040
Why?
Mice, Transgenic
2
2008
1010
0.040
Why?
Lymphatic Metastasis
2
1999
3305
0.040
Why?
Contrast Media
2
2008
563
0.030
Why?
Neoplasm Staging
2
1999
3822
0.030
Why?
Survival Rate
2
1999
4060
0.030
Why?
Disease Progression
2
2007
977
0.030
Why?
Computer Simulation
2
2007
674
0.030
Why?
Chelating Agents
1
2011
46
0.030
Why?
Cytosol
1
2011
122
0.030
Why?
Mice, Inbred C57BL
2
2007
2671
0.030
Why?
Blood Transfusion
1
2011
205
0.020
Why?
Evoked Potentials
1
2009
61
0.020
Why?
Quality Control
1
2009
79
0.020
Why?
Sulfur Hexafluoride
1
2008
1
0.020
Why?
Head
1
2009
54
0.020
Why?
Systole
1
2008
142
0.020
Why?
Functional Laterality
1
2009
228
0.020
Why?
Gadolinium DTPA
1
2008
48
0.020
Why?
Diastole
1
2008
154
0.020
Why?
Reaction Time
1
2009
197
0.020
Why?
Electron Spin Resonance Spectroscopy
1
2007
26
0.020
Why?
Flurbiprofen
1
2007
3
0.020
Why?
Entorhinal Cortex
1
2007
9
0.020
Why?
Metabolic Clearance Rate
1
2007
51
0.020
Why?
Blood Volume
1
2007
41
0.020
Why?
Cyclooxygenase Inhibitors
1
2007
67
0.020
Why?
Albumins
1
2007
72
0.020
Why?
Feasibility Studies
1
2009
614
0.020
Why?
Amyloid beta-Protein Precursor
1
2007
112
0.020
Why?
Sex Characteristics
1
2009
277
0.020
Why?
Electrocardiography
1
2009
575
0.020
Why?
Papio anubis
1
2006
1
0.020
Why?
Fluorocarbons
1
2007
77
0.020
Why?
Respiration
1
2006
90
0.020
Why?
Hydrogen
1
2006
35
0.020
Why?
Neovascularization, Pathologic
1
2007
181
0.020
Why?
Hyperhomocysteinemia
1
2005
15
0.020
Why?
Vitamin B 12 Deficiency
1
2005
17
0.020
Why?
Immunohistochemistry
1
2008
1142
0.020
Why?
Ventricular Function, Left
1
2008
460
0.020
Why?
Logistic Models
1
2009
1373
0.020
Why?
Analysis of Variance
1
2007
1021
0.020
Why?
Social Class
1
2005
121
0.020
Why?
Reference Standards
1
2004
106
0.020
Why?
Internationality
1
2004
70
0.020
Why?
Age Factors
1
2009
1808
0.020
Why?
Epithelium
1
2004
171
0.020
Why?
Heart Ventricles
1
2008
710
0.020
Why?
Ovary
1
2004
93
0.020
Why?
Quality Assurance, Health Care
1
2004
173
0.020
Why?
Research
1
2004
201
0.020
Why?
Nasopharyngeal Neoplasms
1
2002
9
0.020
Why?
Cues
1
2006
654
0.010
Why?
Surveys and Questionnaires
1
2009
2727
0.010
Why?
Research Design
1
2004
711
0.010
Why?
Disease Models, Animal
1
2007
2448
0.010
Why?
Gene Expression Regulation
1
2004
1264
0.010
Why?
Treatment Outcome
1
2002
6794
0.010
Why?
Brown, PhD's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (283)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_